Science Explorer Back to mapMap
Discussion
Hospital / health system · Düsseldorf · Germany

Luisenkrankenhaus

luisenkrankenhaus.deROR OpenAlex
Research works
113
▼ 87% vs 2018-21
Citations
780
6.9 per fractional work
Top-10% rate
5.8%
all institutions 10.0%
Open access
11%
world 40%
International
7%
world 18%
Luisenkrankenhaus

Not ranked overall: Luisenkrankenhaus is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Luisenkrankenhaus work in?

In all years, 59% of research at Luisenkrankenhaus is in Health Sciences, 20% in Social Sciences. Its largest fields are Medicine (54%), Biochemistry, Genetics and Molecular Biology (12%), Arts and Humanities (8%). It does 2.4× the world's share of Health Sciences.

Health Sciences: 67 fractional works · 59.4% of its workMedicine: 61 fractional works · 53.5% of its workSurgery: 16 fractional works · 14.3% of its workPsychiatry and Mental health: 8 fractional works · 6.9% of its workOncology: 6 fractional works · 5.7% of its workDermatology: 5 fractional works · 4.4% of its workPublic Health, Environmental and Occupational Health: 4 fractional works · 3.9% of its workPulmonary and Respiratory Medicine: 3 fractional works · 2.8% of its workNeurology: 3 fractional works · 2.2% of its workRadiology, Nuclear Medicine and Imaging: 2 fractional works · 2.0% of its workPathology and Forensic Medicine: 2 fractional works · 2.0% of its workPhysiology: 2 fractional works · 1.6% of its workEpidemiology: 1 fractional works · 1.3% of its workPharmacology: 1 fractional works · 1.0% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 0.9% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 0.9% of its workAnesthesiology and Pain Medicine: 1 fractional works · 0.7% of its workHematology: 0 fractional works · 0.4% of its workObstetrics and Gynecology: 0 fractional works · 0.4% of its workInfectious Diseases: 0 fractional works · 0.4% of its workComplementary and alternative medicine: 0 fractional works · 0.3% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.3% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 0.3% of its workTransplantation: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.3% of its workHealth Professions: 6 fractional works · 5.7% of its workGeneral Health Professions: 4 fractional works · 4.0% of its workPhysical Therapy, Sports Therapy and Rehabilitation: 1 fractional works · 0.7% of its workComplementary and Manual Therapy: 1 fractional works · 0.6% of its workPharmacy: 1 fractional works · 0.5% of its workVeterinary: 0 fractional works · 0.2% of its workSocial Sciences: 23 fractional works · 20.2% of its workArts and Humanities: 9 fractional works · 7.6% of its workLanguage and Linguistics: 3 fractional works · 2.3% of its workPhilosophy: 2 fractional works · 1.8% of its workVisual Arts and Performing Arts: 1 fractional works · 1.2% of its workMusic: 1 fractional works · 0.6% of its workHistory: 0 fractional works · 0.4% of its workArcheology: 0 fractional works · 0.3% of its workHistory and Philosophy of Science: 0 fractional works · 0.3% of its workLiterature and Literary Theory: 0 fractional works · 0.3% of its workMuseology: 0 fractional works · 0.3% of its workReligious studies: 0 fractional works · 0.3% of its workPsychology: 7 fractional works · 6.0% of its workClinical Psychology: 4 fractional works · 3.6% of its workSocial Psychology: 1 fractional works · 1.0% of its workDevelopmental and Educational Psychology: 1 fractional works · 0.7% of its workApplied Psychology: 0 fractional works · 0.3% of its workExperimental and Cognitive Psychology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workSocial Sciences: 6 fractional works · 5.4% of its workEducation: 3 fractional works · 2.3% of its workCultural Studies: 2 fractional works · 1.8% of its workSociology and Political Science: 1 fractional works · 0.7% of its workGender Studies: 0 fractional works · 0.3% of its workPolitical Science and International Relations: 0 fractional works · 0.3% of its workEconomics, Econometrics and Finance: 1 fractional works · 1.1% of its workEconomics and Econometrics: 1 fractional works · 1.1% of its workBusiness, Management and Accounting: 0 fractional works · 0.2% of its workLife Sciences: 19 fractional works · 17.1% of its workBiochemistry, Genetics and Molecular Biology: 13 fractional works · 11.8% of its workCancer Research: 8 fractional works · 7.0% of its workMolecular Biology: 2 fractional works · 1.6% of its workGenetics: 1 fractional works · 1.2% of its workBiochemistry: 1 fractional works · 0.7% of its workCell Biology: 1 fractional works · 0.6% of its workClinical Biochemistry: 1 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNeuroscience: 6 fractional works · 5.0% of its workCognitive Neuroscience: 3 fractional works · 2.9% of its workNeurology: 1 fractional works · 1.2% of its workEndocrine and Autonomic Systems: 1 fractional works · 0.9% of its workImmunology and Microbiology: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 0 fractional works · 0.2% of its workPhysical Sciences: 4 fractional works · 3.2% of its workEngineering: 2 fractional works · 1.3% of its workBiomedical Engineering: 0 fractional works · 0.4% of its workCivil and Structural Engineering: 0 fractional works · 0.4% of its workMechanical Engineering: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEnvironmental Science: 1 fractional works · 0.7% of its workWater Science and Technology: 0 fractional works · 0.4% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 0.3% of its workMathematics: 1 fractional works · 0.6% of its workGeometry and Topology: 0 fractional works · 0.3% of its workMathematical Physics: 0 fractional works · 0.3% of its workComputer Science: 1 fractional works · 0.6% of its workComputational Theory and Mathematics: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workALL ITS WORKLuisenkrankenhaus113fractional works, all years
Life Sciences17%Physical Sciences3%Health Sciences59%Social Sciences20%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 17 fields, with their numbers
    1. Medicine6153.5%
    2. Health Professions65.7%
    3. Veterinary00.2%
    1. Arts and Humanities97.6%
    2. Psychology76.0%
    3. Social Sciences65.4%
    4. Economics, Econometrics and Finance11.1%
    5. Business, Management and Accounting00.2%
    1. Biochemistry, Genetics and Molecular Biology1311.8%
    2. Neuroscience65.0%
    3. Immunology and Microbiology00.2%
    4. Agricultural and Biological Sciences00.2%
    1. Engineering21.3%
    2. Environmental Science10.7%
    3. Mathematics10.6%
    4. Computer Science10.6%
    5. Materials Science00.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Luisenkrankenhaus?

Ranked on the quality score, Mahdi Rezai, Maren Darsow and Karel Dohnal lead among researchers whose main affiliation is Luisenkrankenhaus.

  1. 1 Mahdi Rezai Germany · #1,595,731 worldwide 9k citations · 281 works
  2. 2 Maren Darsow Germany · #2,345,301 worldwide 859 citations · 42 works
  3. 3 Karel Dohnal Germany · #3,484,129 worldwide 363 citations · 27 works
  4. 4 M. Rezai Germany · #4,157,266 worldwide 123 citations · 22 works
  5. 5 G. Amler Germany · #4,225,274 worldwide 25 citations · 16 works
  6. 6 H. -J. Haase Germany · #4,545,677 worldwide 164 citations · 22 works
  7. 7 H Koester Germany · #4,695,396 worldwide 61 citations · 43 works
  8. 8 T Schaper Germany · #4,870,407 worldwide 17 citations · 15 works
  9. 9 Mehdi Rezai Germany · #5,588,561 worldwide 157 citations · 42 works
All ranked researchers at Luisenkrankenhaus

What are the most cited papers from Luisenkrankenhaus?

The most cited paper from Luisenkrankenhaus is "Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial" (Gϋnter von Minckwitz et al., 2014), with 1,048 citations. Next come "A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study" (714) and "Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial" (594).

Most cited papers
#PaperReleasedCitations
1 Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial Gϋnter von Minckwitz et al. · The Lancet Oncology 30 Apr 2014 1,048
2 A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study S. Loibl et al. · Annals of Oncology Open access 7 May 2019 714
3 Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial Miguel Martín et al. · The Lancet Oncology 626 authors 13 Nov 2017 594
4 Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial Arlene Chan et al. · The Lancet Oncology 12 Feb 2016 569
5 Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial Michael Untch, Sibylle Loibl, Joachim Bischoff et al. · The Lancet Oncology 16 Jan 2012 459
All 61 most cited papers, with filters and sorting

Which keywords describe research at Luisenkrankenhaus?

By fractional works in all years, weighted toward what it does more of than the world: Radiotherapy, Quality of Life, Complications, Gene Expression, Molecular Subtypes, Clinical Practice Guidelines, Neoadjuvant Therapy and Prognostic Markers.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Radiotherapy13▲ 30×8 topics
  2. Quality of Life11▲ 7.0×10 topics
  3. Complications8▲ 15×4 topics
  4. Gene Expression8▲ 12×3 topics
  5. Clinical Practice Guidelines8▲ 12×5 topics
  6. Molecular Subtypes8▲ 77×3 topics
  7. Neoadjuvant Therapy7▲ 29×2 topics
  8. Prognostic Markers7▲ 67×3 topics
  9. Breast Tumours7▲ 127×1 topic
  10. Survival Analysis7▲ 23×2 topics
  11. Treatment Response7▲ 127×1 topic
  12. Breast Reconstruction7▲ 98×2 topics
  13. Acellular Dermal Matrix5▲ 225×1 topic
  14. Patient-Reported Outcome Measure5▲ 225×1 topic
  15. Anaesthesia5▲ 211×1 topic
  16. Medical Gases5▲ 211×1 topic
  17. Epidemiological Study4▲ 51×2 topics
  18. Breast Cancer4▲ 14×9 topics
  19. Metastatic Breast Cancer4▲ 56×2 topics
  20. Treatment4▲ 2.9×12 topics
  21. Chronic Diseases4▲ 12×2 topics
  22. Germany4▲ 106×1 topic
  23. Health Surveys4▲ 106×1 topic
  24. Philosophy4▲ 7.1×3 topics
  25. Chemotherapy4▲ 4.5×10 topics
  26. Anxiety3▲ 8.2×3 topics
  27. Emotion Regulation3▲ 9.2×3 topics
  28. Chemotherapy-Induced Peripheral Neuropathy3▲ 58×1 topic
  29. Genetic Testing3▲ 18×3 topics
  30. Taxanes3▲ 58×1 topic
  31. Medical Ethics3▲ 16×2 topics
  32. Telemedicine3▲ 26×2 topics
  33. Informed Consent3▲ 30×2 topics
  34. Interoception3▲ 82×1 topic
  35. Somatic Symptoms3▲ 82×1 topic
  36. Patient Rights3▲ 25×1 topic
  37. Reproductive Medicine3▲ 97×1 topic
  38. Social Cognition3▲ 13×2 topics
  39. Crisis Resolution3▲ 98×1 topic
  40. Home Treatment3▲ 98×1 topic

Which research topics does Luisenkrankenhaus publish most on?

By volume in 2022-now: Schizophrenia research and treatment, Chemotherapy-related skin toxicity, Cancer Treatment and Pharmacology and Personality Disorders and Psychopathology.

Schizophrenia research and treatment: 0 fractional worksChemotherapy-related skin toxicity: 0 fractional worksCancer Treatment and Pha…0Cancer Treatment and Pharmacology: 0 fractional worksPersonality Disorders an…0Personality Disorders and Psychopathology: 0 fractional worksPsychopathy, Forensic Psychiatry, Sexual Offending: 0 fractional worksOral health in cancer treatment: 0 fractional worksNausea and vomiting management: 0 fractional worksBreast Cancer Treatment Studies: 0 fractional worksLung Cancer Diagnosis and Treatment: 0 fractional worksAdvanced Breast Cancer Therapies: 0 fractional works
Psychiatry and Mental healthDermatologyOncologyClinical Psychology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Schizophrenia research and treatment Psychiatry and Mental health 0 works
  2. 2 Chemotherapy-related skin toxicity Dermatology 0 works
  3. 3 Cancer Treatment and Pharmacology Oncology 0 works
  4. 4 Personality Disorders and Psychopathology Clinical Psychology 0 works
  5. 5 Psychopathy, Forensic Psychiatry, Sexual Offending Clinical Psychology 0 works
  6. 6 Oral health in cancer treatment Pulmonary and Respiratory Medicine 0 works
  7. 7 Nausea and vomiting management Surgery 0 works
  8. 8 Breast Cancer Treatment Studies Cancer Research 0 works
  9. 9 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 0 works
  10. 10 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available11.1%not open88.9%

World: 40% of research is openly available.

with international co-authors7.4%domestic only92.6%

World: 18% is written across borders.

How has Luisenkrankenhaus's research output changed?

Output in 2022-2025 was 87% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Luisenkrankenhaus as a percentage of every work published that year, 0.000020% in 2024.

still counting0.00025%0.00050%0.00075%Luisenkrankenhaus0.000015% in 202519801990200020102020

Fractional works of Luisenkrankenhaus over all fractional works that year. How the balance of science has shifted.

Other research institutions in Düsseldorf

All research institutions in Düsseldorf

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Luisenkrankenhaus. Posts are plain text and can be reported.